LP-118
N/A
Report date: 2026/05/06 20:02:28
NME
Base Information
Drug NameLP-118
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[15]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou Lupeng Pharmaceutical Co LtdNewave Pharmaceutical Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesNewave Pharmaceutical IncThe University Of ChicagoGuangzhou Lupeng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications +[14]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A